Showing 51-60 of 91 results for "".
- Dermira's Investigational AD Drug Performs Well in Phase 2b Trial, Shares Skyrockethttps://practicaldermatology.com/news/ready-for-phase-3-dermiras-investigational-ad-drug-performs-well-in-phase-2b-trial/2459969/All three doses of Dermira, Inc.’s lebrikizumab showed greater improvements in the Eczema Area and Severity Index in a new Phase 2b dose-ranging study of adults with moderate-to-severe atopic dermatitis, and shares of Dermira, Inc. skyrocketed in premarket trading after the company announced these …
- RealSelf Forms Strategic Medical Advisory Councilhttps://practicaldermatology.com/news/realself-forms-strategic-medical-advisory-council/2457540/RealSelf, Inc. has formed a Strategic Medical Advisory Council with three operating boards. The RealSelf Strategic Advisory Council is made up of the Business Advisory Board, the Medical Review Advisory Board and the Industry Advisory Board, all of which are comprised of board-certified doctors and…
- Naked Eye, Smart Phone Apps May Miss Melanomashttps://practicaldermatology.com/news/naked-eye-smart-phone-apps-may-miss-melanomas/2457486/The naked eye alone is not enough to accurately diagnosis skin cancer and smart phone apps may also miss melanomas, according to a new review published in The Cochrane Library as part of a Special Collection of Cochrane Systematic Reviews bringing together a large body of research on the accuracy o…
- Sonoma Pharmaceuticals Launches New Ceramax Skin Barrier Lotionhttps://practicaldermatology.com/news/sonoma-pharmaceuticals-launches-new-ceramax-skin-barrier-lotion/2457504/Sonoma Pharmaceuticals, Inc. has launched a new Ceramax™ Skin Barrier Lotion that complements Sonoma’s current Ceramax Skin Barrier Cream. Both Ceramax products contain skin-enriching technology that helps manage dry itchy skin, minor skin irritations, rashes and inflammation caused by various skin…
- Pennsylvania Passes SUNucate, Allowing Sunscreen Use and Protective Clothing at Schoolhttps://practicaldermatology.com/news/pennsylvania-passes-sunucate-allowing-sunscreen-use-and-protective-clothing-at-school/2457529/Pennsylvania became the 17th state to allow children to possess and apply sunscreen at school. Governor Tom Wolf approved HB 1228, a piece of legislation based on American Society for Dermatologic Surgery Association’s (ASDA) model bill known as SUNucate to remove barriers that prohibit students f…
- ISDIN Launches Melatonik Nighttime Serumhttps://practicaldermatology.com/news/isdin-launches-melatonik-nighttime-serum/2457577/ISDIN's Melatonik nighttime serum formulated with melatonin, bakuchiol (a natural antioxidant with retinol-like properties) and Vitamin C, is now available. It was developed to help skin recover from the day and prepare it to fight the stresses of tomorrow, ISDIN says. Melatonik stimulates the sk…
- Dermira's Qbrexa Cloth Now Available for Primary Axillary Hyperhidrosishttps://practicaldermatology.com/news/dermiras-qbrexa-cloth-now-available-for-primary-axillary-hyperhidrosis/2457582/Dermira, Inc.'s Qbrexa (glycopyrronium) cloth is now available for prescribing to treat primary axillary hyperhidrosis. The new therapy is available in retail and community pharmacies nationwide. In June 2018, QBREXZA, a once-daily, prescription anticholinergic, was FDA approved to treat adult and …
- TruDerm Adds Second Dermatology Centerhttps://practicaldermatology.com/news/truderm-adds-second-dermatology-center/2457681/TruDerm, a growing medical and cosmetic dermatology practice offering skin care seven days a week is opening its second DFW facility in Plano, TX at Legacy West. Staffed by Board Certified Dermatologist, Dr. Max Adler and a team of seasoned skin care professionals, TruDerm's retail-forward approa…
- FDA Approves Dermira's Qbrexza Cloth to Treat Primary Axillary Hyperhidrosishttps://practicaldermatology.com/news/fda-approves-delmiras-qbrexza-cloth-to-treat-primary-axillary-hyperhidrosis/2457709/The FDA has approved Qbrexza™ (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older. Qbrexza is applied directly to the skin and is designed to block sweat production by inhibiting sw…
- New Patient-Centered Panel Helps BioPharmX Define its Role in the Future of Dermatologyhttps://practicaldermatology.com/news/new-patient-centered-panel-helps-biopharmx-define-its-role-in-the-future-of-dermatology/2457721/BioPharmX Corporation has formed a Special Advisory Council of thought leaders from various disciplines to help the company embrace patient centricity in its products, pricing, and market access considerations. The advisors, who bring decades of experience in fields beyond dermatology—ranging from…